A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells
Authors
Keywords
-
Journal
NATURE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-02-24
DOI
10.1038/s41586-022-04439-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The PSMA Targeting Half-Life Extended BiTE® Therapy AMG 160 Has Potent Antitumor Activity in Preclinical Models of Metastatic Castration-Resistant Prostate Cancer
- (2021) Petra Deegen et al. CLINICAL CANCER RESEARCH
- T cell-engaging therapies — BiTEs and beyond
- (2020) Maria-Elisabeth Goebeler et al. Nature Reviews Clinical Oncology
- 609O Results from a phase I study of AMG 160, a half-life extended (HLE), PSMA-targeted, bispecific T-cell engager (BiTE®) immune therapy for metastatic castration-resistant prostate cancer (mCRPC)
- (2020) B. Tran et al. ANNALS OF ONCOLOGY
- Targeting Multiple Myeloma with AMG 424, a Novel Anti-CD38/CD3 Bispecific T Cell-Recruiting Antibody Optimized for Cytotoxicity and Cytokine Release
- (2019) Christina L. Zuch de Zafra et al. CLINICAL CANCER RESEARCH
- T Cell–Activating Bispecific Antibodies in Cancer Therapy
- (2019) Asaad Trabolsi et al. JOURNAL OF IMMUNOLOGY
- Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer
- (2018) S Siena et al. ANNALS OF ONCOLOGY
- SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)
- (2018) Ganesh Raghu et al. EUROPEAN RESPIRATORY JOURNAL
- Concurrent administration of anti-HER2 therapy and radiotherapy: Systematic review
- (2017) Fabien Mignot et al. RADIOTHERAPY AND ONCOLOGY
- An FDA oncology analysis of CD3 bispecific constructs and first-in-human dose selection
- (2017) Haleh Saber et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques
- (2017) Ling Xu et al. SCIENCE
- The frequency and clinical impact of HER2 alterations in lung adenocarcinoma
- (2017) Eun Kyung Kim et al. PLoS One
- Toxicities of chimeric antigen receptor T cells: recognition and management
- (2016) Jennifer N. Brudno et al. BLOOD
- Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy
- (2016) V. G. Bhoj et al. BLOOD
- CODV-Ig, a universal bispecific tetravalent and multifunctional immunoglobulin format for medical applications
- (2016) Anke Steinmetz et al. mAbs
- Blinatumomab
- (2015) Larry W. Buie et al. ANNALS OF PHARMACOTHERAPY
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- HER2 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma
- (2014) Netanya I. Pollock et al. CLINICAL CANCER RESEARCH
- HER2 Dimerization Inhibitor Pertuzumab - Mode of Action and Clinical Data in Breast Cancer
- (2013) Nadia Harbeck et al. Breast Care
- Association of HER2/ErbB2 Expression and Gene Amplification with Pathologic Features and Prognosis in Esophageal Adenocarcinomas
- (2012) H. H. Yoon et al. CLINICAL CANCER RESEARCH
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resistance to Trastuzumab in Breast Cancer
- (2009) P. R. Pohlmann et al. CLINICAL CANCER RESEARCH
- Evolving novel anti-HER2 strategies
- (2009) Kellie L Jones et al. LANCET ONCOLOGY
- HER2+ Breast Cancer
- (2008) David G. Hicks et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
- (2008) C. Gravalos et al. ANNALS OF ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now